MCL-1 inhibition in cancer treatment
Weiguo Xiang,1 Chao-Yie Yang,1,2 Longchuan Bai1,2 1Department of Internal Medicine, University of Michigan Medical School, 2Rogel Cancer Center, University of Michigan, Ann Arbor, MI, USA Abstract: Myeloid cell leukemia-1 (MCL-1), a member of antiapoptotic BCL-2 family proteins, is a key regulator...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2018-10-01
|
Series: | OncoTargets and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/mcl-1-inhibition-in-cancer-treatment-peer-reviewed-article-OTT |